Home › NDC Lookup › Ingredients › Esokalli Delay Performance Gel › 84778-0103-02
ESOKALLI Delay Performance Gel .1 g/100mL; 2 g/100mL Gel, 2 tubes — NDC 84778-0103-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

ESOKALLI Delay Performance Gel .1 g/100mL; 2 g/100mL Gel, 2 tubes — NDC 84778-103-02 (Billing 84778-0103-02)

by Guangzhou Yixin Cross-border E-commerce Co., Ltd. · 2 TUBE in 1 BOX / 1.8 mL in 1 TUBE

This is a package of 2 tubes of ESOKALLI Delay Performance Gel .1 g/100mL; 2 g/100mL Gel from Guangzhou Yixin Cross-border E-commerce Co., Ltd., no longer marketed (first marketed Aug 2025), no longer in the FDA NDC Directory.

NDC 84778-0103-02
🏷️ FDA NDC (as labeled) 84778-103-02 billing pads the product segment with a zero
This package
Contains2 tubes Pack sizes4 compare ↓
Product page 84778-0103-01 Also comes in: 1.8 mL 84778-103-01 3 tubes 84778-103-03 4 tubes 84778-103-04
OTC Discontinued Non-controlled ⚠ Inactivated by FDA ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 84778-103-02 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
84778 labeler · 103 product · 02 package
Package marketed since
Aug 24, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 8477810302 7
FDA record last changed
Jul 24, 2026
⚠️
Excluded from the active FDA NDC Directory. FDA inactivated this product’s listing record, so it is excluded from the active NDC Directory. The listing was last certified through Dec 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 84778-103-02
Product NDC 84778-103
11-digit billing NDC 84778010302
UNII 98PI200987, 94ZLA3W45F
Application # 505G(a)(3)
SPL Set ID 41f89c38-32c2-f2fa-e063-6294a90ad6bd
Established class (EPC) Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Local Anesthesia
Chemical class Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Inactivated by FDA (certified through Dec 2026)
Marketing start 2025-08-24
Route TOPICAL
Dosage form GEL
Substance LIDOCAINE; ARGININE
Why two NDCs? The FDA registers this code as 84778-103-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 84778-0103-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an over-the-counter topical gel marketed under FDA's OTC monograph rules for its category. It contains lidocaine, a local anesthetic commonly used in topical products to numb or reduce sensation in the area where it is applied. The product also contains arginine, an amino acid that appears in various personal-care and wellness formulations. The gel is intended for topical application to the skin.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 1.8 mL 3 tubes 4 tubes
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
84778-0103-01 84778-103-01 Main listing 1 TUBE in 1 BOX / 1.8 mL in 1 TUBE 2025-08-24 — Inactivated by FDA
84778-0103-02 You're viewing this 2 TUBE in 1 BOX / 1.8 mL in 1 TUBE 2025-08-24 — Inactivated by FDA
84778-0103-03 84778-103-03 3 TUBE in 1 BOX / 1.8 mL in 1 TUBE 2025-08-24 — Inactivated by FDA
84778-0103-04 84778-103-04 4 TUBE in 1 BOX / 1.8 mL in 1 TUBE 2025-08-24 — Inactivated by FDA

Pack size FAQ

What quantity is in this package?
This package contains 2 tubes — 2 tube in 1 box / 1.8 ml in 1 tube.
How does this package differ from NDC 84778-0103-01?
Both are ESOKALLI Delay Performance Gel .1 g/100mL; 2 g/100mL Gel — the drug itself is identical. This page's package is the 2 tubes one, while NDC 84778-0103-01 is the 1 tube package.
What NDC number is used to bill for this package of ESOKALLI Delay Performance Gel .1 g/100mL; 2 g/100mL Gel?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
ESOKALLI Delay Performance Gel .1 g/100mL; 2 g/100mLthis 84778-0103-02 Guangzhou 2 tubes — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Aug 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII WZH3C48M4T
    Potassium hydroxide is a strong alkaline chemical used in medicines to adjust and maintain the pH level of liquid formulations, helping keep the product stable and the active ingredients effective.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

4 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAnhydrous Alcohol, Glycerin, Propylene Glycol, Carbomer, Purified Water, Potassium Hydroxide.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGuangzhou Yixin Cross-border E-commerce Co., Ltd.
FDA application505G(a)(3) (OTC MONOGRAPH DRUG)
Labeler code84778
First marketedAug 2025
Product typeHuman Otc Drug
Portfolio29 products on file

More NDCs from Guangzhou Yixin Cross-border E-commerce Co., Ltd... labeler code 84778

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 17 words ▾

Uses: Helps temporarily reduce sensitivity for better control. Supports local blood flow for enhanced firmness and endurance.

⏱️ Dosage and Administration 28 words ▾

Dosage and Administration Apply a small amount (pea-sized) to the glans or desired area 5–10 minutes before activity. Allow to absorb completely before contact. Wash off after use.

⚠️ Warnings 76 words ▾

Warnings: For external use only. Avoid contact with eyes or broken or irritated skin. Do not use if allergic to Lidocaine or other local anesthetics.

Do not use if you have heart disease, have undergone heart stent placement, or are taking nitrate-based medications (such as nitroglycerin or isosorbide dinitrate). The vasodilating effect of L-Arginine may affect cardiovascular stability. Stop use and consult a doctor if irritation, rash, or burning occurs.

Keep out of reach of children.

🧪 Inactive Ingredients 12 words ▾

Inactive ingredients Anhydrous Alcohol, Glycerin, Propylene Glycol, Carbomer, Purified Water, Potassium Hydroxide.

🎯 Purpose 7 words ▾

Purpose: Male desensitizing and performance enhancement gel.

📄 Do Not Use 80 words ▾

Do not use if you: For external use only. Avoid contact with eyes or broken or irritated skin. Do not use if allergic to Lidocaine or other local anesthetics.

Do not use if you have heart disease, have undergone heart stent placement, or are taking nitrate-based medications (such as nitroglycerin or isosorbide dinitrate). The vasodilating effect of L-Arginine may affect cardiovascular stability. Stop use and consult a doctor if irritation, rash, or burning occurs.

Keep out of reach of children.

📄 When Using This Product 22 words ▾

When using this product you may experience: headache, flushing, indigestion, nasal congestion, dizziness, muscle pain, back pain, nausea, rash, or visual disturbances

📄 Stop Use and Ask a Doctor If 30 words ▾

Stop use and ask a doctor if: you experience chest pain, fainting, sudden vision or hearing loss an erection lasts longer than 4 hours (priapism). This is a medical emergency.

📄 Keep Out of Reach of Children 17 words ▾

Contraindications Not for use in pregnant or breastfeeding women Not for use in children under 18 years

📄 Package Label / Principal Display Panel 7 words ▾

PRINCIPAL DISPLAY PANEL 01 02 03 04

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 1 tube (84778-0103-01), 3 tubes (84778-0103-03), 4 tubes (84778-0103-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Guangzhou Yixin Cross-border E-commerce Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 84778-0099-01 · Guangzhou 84778-0105-01 · Guangzhou →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.